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Abstract
The immune system can recognize virtually any antigen, yet T cell responses against sever-
al pathogens, includingMycobacterium tuberculosis, are restricted to a limited number of
immunodominant epitopes. The host factors that affect immunodominance are incompletely
understood. Whether immunodominant epitopes elicit protective CD8+ T cell responses or
instead act as decoys to subvert immunity and allow pathogens to establish chronic infec-
tion is unknown. Here we show that anatomically distinct human granulomas contain clonal-
ly expanded CD8+ T cells with overlapping T cell receptor (TCR) repertoires. Similarly, the
murine CD8+ T cell response againstM. tuberculosis is dominated by TB10.44-11-specific
T cells with extreme TCRβ bias. Using a retrogenic model of TB10.44-11-specific CD8+ T
cells, we show that TCR dominance can arise because of competition between clonotypes
driven by differences in affinity. Finally, we demonstrate that TB10.4-specific CD8+ T cells
mediate protection against tuberculosis, which requires interferon-γ production and TAP1-
dependent antigen presentation in vivo. Our study of how immunodominance, biased TCR
repertoires, and protection are inter-related, provides a new way to measure the quality of T
cell immunity, which if applied to vaccine evaluation, could enhance our understanding of
how to elicit protective T cell immunity.
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Author Summary
While T cells are required for protection againstMycobacterium tuberculosis infection, at-
tempts to prevent tuberculosis by vaccines designed to elicit memory T cells have only
been partially successful. Several vaccine candidates are in clinical trials, but progress has
been slow because their ability to prevent disease must be empirically tested. There is little
understanding of why certain antigens are targets of protective immunity. We have char-
acterized an immunodominant CD8+ T cell response to theM. tuberculosis antigen
TB10.4 (EsxH). CD8+ T cells specific for the TB10.44–11 epitope are primed early during
infection and account for 30–50% of lung CD8+ T cells during chronic infection. Now we
have used deep sequencing to characterize the TCR repertoire of TB10.44-11-specific CD8
+
T cells in the lungs of infected mice. Interestingly, TB10.44-11-specific CD8
+ T cells exhibit
extreme clonal expansion of certain TCRβ with common structural features, most likely
because of affinity selection. Affinity selection of T cells is more important when antigen
presentation is limiting. Although the lung contains numerous bacteria during infection,
antigen-presentation by infected APC may be limiting, mimicking a “low antigen” state.
Thus, even T cells that have the potential to mediate protection may function inefficiently
because of suboptimal T cell activation.
Introduction
The adaptive immune system can generate 1014 unique TCRs, which provides the capacity to
recognize an enormous universe of distinct antigens [1–4]. Despite our understanding of the
genetic and structural basis for TCR diversity and antigen recognition, it remains challenging
to predict the magnitude and diversity of T cell responses. The size of the T cell response to
model antigens generally correlates with the abundance of antigen-specific T cells in the naïve
repertoire (e.g., precursor frequency) [5–7]. Paradoxically, pathogen-specific T cell responses
are often focused on a small number of the available antigenic epitopes and use a narrow TCR
repertoire, a phenomenon termed “immunodominance”. Pathogens have numerous strategies
to evade host immunity, hindering our ability to determine a priori how T cell diversity relates
to antimicrobial immunity. Thus, the relationship between immunodominance and host de-
fense during infection is incompletely understood. For pathogens that rapidly mutate, such as
human immunodeficiency virus 1 (HIV-1), a diverse T cell response could benefit the host by
efficiently detecting escape mutants, while a biased response could be detrimental. For slowly
replicating pathogens that encode numerous antigens, the relation between diversity and pro-
tection is less clear.
TheM. tuberculosis genome contains hundreds of epitopes that can potentially be recog-
nized by murine and human CD8+ T cells [8]. The CD8+ T cell response againstM. tuberculosis
focuses on the TB10.4 protein (EsxH; Rv0288) in people as well as experimentally infected ani-
mals [8–13]. Following aerosol infection of C57BL/6 mice, 30–50% of the responding CD8+ T
cells in the lungs recognize the Kb-restricted epitope TB10.44–11 (amino acid sequence IMYNY-
PAM), defining it as an immunodominant epitope [14–16]. Immunodominant T cell responses
in patients with tuberculosis have been suggested to be both a correlate of protection and a
marker of disease progression [17–20]. Elucidating how immunodominance arises and affects
resistance to infection is crucial for developing successful vaccines, which usually target a limit-
ed number of antigens.
Here, we investigated the origin and protective capacity of immunodominant T cell re-
sponses followingM. tuberculosis infection in both humans and mice. Extreme TCR bias, the
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presence of public TCRs, and strong selection of a complementarity determining region 3
(CDR3) βmotif were shown by TCR sequencing of sorted tetramer+ cells from the lungs of in-
fected mice. We discovered that TCR bias emerges soon after T cell priming in the lymph node
(LN) and becomes more extreme during chronic infection. Cloning TB10.44-11-specific TCRs
allowed us to develop retrogenic (Rg) mice to study immunodominant TCRs in vivo. Competi-
tion studies using TB10.44-11-specific Rg CD8
+ T cells showed that small differences in T cell
affinity lead to clonal dominance in vivo. Finally, TB10.44-11-specific CD8
+ T cells transferred
IFNγ-dependent protection againstM. tuberculosis infection that required TAP1-dependent
antigen presentation.
Results
Human CD8+ T cell expansions in lung granulomas
Deep sequencing of the TCRβ repertoire was performed on CD8+ T cells purified from 11 lung
granulomas and one LN obtained from 5 patients undergoing lung resection for medically
non-responsive tuberculosis (see Table 1, S1 Data). The CD8+ T cells in the granulomas were
more clonal than the peripheral blood TCRβ repertoire of healthy individuals (Fig 1A and S2A
Data). TCRβ expansions were detected in all lung samples (Fig 1B and S3 Data). Abundant clo-
notypes were detected in anatomically distinct granulomas from the same patient (Fig 1B).
There was extensive overlap of the TCR sequences between granulomas from the same patient,
although most sequences detected in each granuloma were unique to that lesion (Fig 1C).
However, it was the shared sequences that were most abundant. For example, of 217 TCRβs
common to all three granulomas from patient #23, 143 were the most abundant in each lesion
(the top 10 are shown in Fig 1C and S2B Data). Thus, the same T cells clonotypes were abun-
dant in different lesions from the same subject despite their varied pathology (see Table 1).
Some TCRβs appeared to have undergone antigen-selection, as sequences with identical
CDR3β amino acid sequences were encoded by distinct recombination events. For example,
five distinct DNA recombination events led to the CDR3β sequence ‘CASSVDGGTEAFF’ and
two occurred at a high frequency (1.16% and 0.9%, Fig 1D). Thus, CD8+ T cells in human gran-
ulomas undergo clonal expansion, and while there is considerable heterogeneity between dis-
tinct lesions, the most abundant clonotypes were shared between granulomas. As the antigen-
specificity and the HLA restriction of these T cells were unknown, the inferences that we can
make are limited. Furthermore, co-infection with HIV, present in four of the five subjects,
Table 1. Clinical characteristics of subjects.
case TB Dx Rx
initiated
Resection MDR XDR HIV status samples
0021 02/2003 9/9/12 6/24/14 Yes No positive on
ART
extensive disease and evidence of mycetoma
0023 03/2012 9/15/12 6/17/14 Yes
unknown
positive on
ART
A-Right upper lobe (RUL)- purulent, extensive cavities B-Right middle lobe
(RML)- no cavities but evidence of disease C-Right lower lobe (RLL), least
involved but still evidence of disease
0024 unknown 6/15/13 6/9/14 Yes
unknown
negative A-RUL, extensive cavities B-RML, no cavities but evidence of disease C-RLL
least involved but still evidence of disease
0026 12/2012 5/10/14 5/27/14 No No positive on
ART
A LUL- extensive cavities and calciﬁed lesions B LLL- apparently healthy tissue
0027 06/2012 1/15/14 6/3/14 No No positive on
ART
A RUL—Diseased tissue, cavities throughout B RML—No cavities but evidence
of involvement
TB, tuberculosis; Dx, diagnosis; Rx, treatment; MDR, multidrug-resistant TB; XDR, extensively drug-resistant TB; ART, anti-retroviral therapy.
doi:10.1371/journal.ppat.1004849.t001
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Fig 1. Human CD8+ T cells undergo clonal expansions in lung granulomas. (a) Clonality of CD8+ TCR sequences obtained from pulmonary
granulomas (n = 11) compared to PBMC from healthy donors (n = 26); p = 0.0002 by Mann-Whitney. (b) The frequency of the top ten clones in each sample.
Clones shared between samples are connected with a line. (c) TCRVβ chains are shared among anatomically distinct granulomas from the same patient. A
Venn diagram shows the overlap of unique TCRs from samples 23A, 23B, and 23C. The CDR3β amino acid sequences of the 10 most frequent clones that
are shared by the 3 lesions are shown, along with their respective frequency in each lesion. (d) TCR selection suggested by distinct DNA sequences that
encode the same CDR3β amino acid sequence. Sample 23LGCD8B contains five distinct recombination events encode the CDR3β amino acid sequence
“CASSVDGGTEAFF.” Yellow shading, 3’ Vβ gene sequence; boxed sequence, D nucleotides; green shading, 5’ Jβ gene sequence; bold red letters indicate
differences in the sequences. Other differences exist in the Vβ gene sequences. The respective frequency of each sequence is shown.
doi:10.1371/journal.ppat.1004849.g001
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could potentially confound the analysis, since HIV itself can alter the TCR repertoire of CD8+
T cells. Indeed, we cannot be certain whether these TCRs are specific for Mtb. Therefore, we
next turned to an animal model of tuberculosis to address the origin and consequences of clon-
al CD8+ T cell expansions.
The TB10.4-specific CD8+ T cell response is highly biased
TheM. tuberculosis epitope TB10.44–11 elicits an immunodominant CD8
+ T cell response in
both people and mice [10,21]. To determine whether the number of distinct clonotypes among
the responding T cells was limited or diverse, we sorted TB10.44-11-tetramer
+CD8+ T cells
from the lungs of six individual mice, infected withM. tuberculosis for nine weeks. Deep se-
quencing showed that the CD8+ T cell response to TB10.44–11 was significantly more clonal
than the T cell repertoire from uninfected mice (Fig 2A). The TCRβ repertoire of each infected
mouse was dominated by large expansions of two or three clones, although the dominant Vβ
gene varied between individuals (Fig 2B). The dominance of TCRβ chains with identical
CDR3β sequences indicated that the TB10.44-11-specific CD8
+ T cell response was oligoclonal
(Fig 2C).
To determine whether TCR bias was established during priming in the LN or after T cell
trafficking to the lungs, we used monoclonal antibodies (mAbs) specific for a subset of the
known Vβ families (see Table 2). All 5 Vβ families were expressed by CD8+ T cells obtained
from LNs of mice 21 days after infection, the majority of which are not specific for Mtb (Fig
2D). The distribution of these 5 Vβ families among tetramer+ cells in the LN was similar to the
bulk CD8+ T cell population (Fig 2D). Starting on day 21 in the lung, and more dramatically by
day 28 in the LN and lung, significant Vβ family bias was detected among TB10.44-11-specific
CD8+ T cells. For example, Vβ4 (mouse ‘A’ and ‘B’), Vβ7 (mouse ‘B’), or Vβ10 (mouse ‘C’)
dominated the TB10.44-11-specific CD8
+ T cell response by day 21 post infection (Fig 2E). The
dominant Vβ family was frequently expanded in both the LN and lung, suggesting that TCR
bias developed early after T cell priming. Overtime, biases became more dramatic, suggesting
ongoing preferential expansion of certain clones. The TB10.44-11-specific CD8
+ T cells in one
infected mouse (mouse ‘H’) were>80% Vβ7+ after 25 weeks of infection (Fig 2E and 2‘H’).
Thus, after an initial priming of a broad repertoire in response to antigen, TCR bias among
TB10.44-11-specific CD8
+ T cells develops in the draining LN early after T cell priming and be-
comes established during the chronic phase of infection. The highly oligoclonal response and
the dominance of CDR3β amino acid sequences suggest that the immunodominant T cell clo-
notypes undergo selection during infection.
The paradox of high precursor frequency and extreme TCR bias
Two general mechanisms can explain how TCR bias develops during the TB10.44–11 response:
1) TB10.44-11-specific CD8
+ T cells are drawn from a limited pool of naïve precursors; or 2) the
naïve TB10.44-11-specific CD8
+ T cells pool is diverse but competition leads to selection and
bias. To discriminate between these possibilities, we measured the precursor frequency of
TB10.44-11-specific CD8
+ T cells in uninfected mice.
Using sequential tetramer staining and enrichment of antigen-specific T cells from the
naïve repertoire [5,22], we determined that approximately 1:13,000 CD8+ T cells were specific
for the TB10.44–11 epitope in the C57BL/6 naïve repertoire, or about 857 cells per mouse (Fig
3A and 3B). This precursor frequency is among the highest recorded for antigen-specific CD8+
T cells in the mouse [7].
The high frequency of TB10.44-11-specific CD8
+ T cell precursors in C57BL/6 mice contrasts
with the limited number of unique T cell clonotypes that comprise the post-infection
CD8+ T Cell Selection during Chronic Infection
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Fig 2. Clonal expansions of CD8+ T cells specific for the immunodominant antigen TB10.4. (a)
Clonality of CD8+ TCR sequences obtained from infected lung granulomas (n = 6) compared to splenocytes
from uninfected mice (n = 9); p = 0.0004 by Mann-Whitney. (b,c) Frequency of TCR Vβ families (b) and
CDR3βs (c) of TB10.44-11-specific CD8
+ T cells from the lungs of C57BL/6J mice infected withM.
tuberculosis for 9 weeks. Data were obtained by Next-generation sequencing of tetramer-purified T cells from
6 individual mice. (d) Frequency of TCR Vβ4 (TRBV2), Vβ5 (TRBV12), Vβ7 (TRBV29), Vβ10 (TRBV4) and
Vβ11 (TRBV16) families of TB10.44-11-tetramer
+CD8+T (red) or TB10.44-11-tetramer
-CD8+T (blue) cells from
the pulmonary LN of C57BL/6J mice infected withM. tuberculosis at 21 days post infection. (e) Frequency of
TCR Vβ4 (TRBV2), Vβ7 (TRBV29) and Vβ10 (TRBV4) families of CD8+ T cells from the pulmonary LN or
CD8+ T Cell Selection during Chronic Infection
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TB10.44-11-specific CD8
+ T cell repertoire. To estimate the frequency of TB10.44-11-specific
TCRβ clones in the naïve repertoire, TB10.44-11-specific sequences from infected mice were
used to interrogate data sets from three uninfected C57BL/6 mice (referred to below as spleen
A, B, or C) each containing more than a million TCRβ sequences (Provided by David Hamm,
Adaptive Biotechnologies reference data "Mus musculus TCR Beta from spleen", 2014). By per-
forming a pairwise comparison, we identified TB10.44-11-specific TCRβ DNA sequences in the
naïve T cell repertoire of uninfected mice (Fig 3C). For example, an abundant TCRβ from the
lung of infected mouse #2 (17.8%) was present in spleen B (0.0026%); however, none of the
abundant (>0.1%) TCRβs from the lung of infected mouse #2 were present in spleen A or C
(Fig 3C). When the translated CDR3β amino acid sequences were used to query the naïve rep-
ertoire, the number of matches increased from 40 to 345; and several of the most highly repre-
sented CDR3βs were identified (Fig 3D). This raises the possibility that there are multiple
DNA recombination events that can generate CDR3β regions capable of recognizing TB10.44–
11 in the naïve repertoire. Importantly, the frequencies of TB10.44–11–associated TCRβs in the
naïve repertoire were similar to the median frequency determined for the entire naïve T cell
population (Fig 3E). For example, the median frequency of the clonotypes detected in naïve
spleen #B was 0.0011%. The frequencies of “CASSQDRENSDYTF” and “CASSRDRENS-
DYTF” in the naïve spleen #B repertoire were 0.00425% and 0.00106%, respectively. Thus, the
low frequency of these two CDR3β regions in the naïve TCR repertoire does not predict their
massive clonal expansion after infection.
To make this analysis more quantitative, we determined the frequencies of all TB10.44-11-as-
sociated CDR3β sequences that could be identified in any of the three uninfected spleens (A, B,
or C). Those sequences (“TB10-associated”, Fig 3E) had a slightly higher median frequency
than the median of the entire splenic TCR repertoire (“uninfected spleen) (0.001845% vs.
0.001142%, P< 0.0001). We next focused on the subset of “TB10-associated” CDR3βs that
were present in at least 2 of the 6 infected lungs, and defined these as “shared sequences” (Fig
3E). The median frequency of the “shared sequences” was 0.003614%, which was increased
compared to “uninfected spleen” (P< 0.0001); this is in agreement with previous observations
describing a higher frequency of public TCRs in the naïve repertoire [2]. Finally, the CDR3βs
that we defined as “expanded sequences” (those with a frequency>1% among CD8+ T cells in
the Mtb-infected lung and that account for 75% of the total TB10.44-11-associated sequences)
lung of C57BL/6J mice infected withM. tuberculosis at 21 days (left panel), 28 days (middle panel) or >25
weeks (right panel) post infection. Dotted lines connect data from individual mice, some of which are labeled
(A through I) to highlight mice with biased Vβ family usage. Data were obtained by flow cytometric analysis of
TB10.44-11-tetramer
+CD8+ T cells (Tet+) or TB10.44-11-tetramer
-CD8+ T cells (Tet-) from three independent
experiments, each with 4–10 mice per group.
doi:10.1371/journal.ppat.1004849.g002
Table 2. Anti-TCR antibodies and their specificity.
mAb clone Commercialdesignation TRAV/TRBV gene family1
B20.1 Va2 TRAV14
KT4 Vb4 TRBV2
MR9-4 Vb5 TRBV12-1, TRBV12-2
TR310 Vb7 TRBV29
B21.5 Vb10 TRBV4
RR3-15 Vb11 TRBV16
1 Based on data from http://www.imgt.org
doi:10.1371/journal.ppat.1004849.t002
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Fig 3. Precursor frequency of TB10.4-specific T cells. (a,b) Frequency of TB10.44-11-specific CD8
+ T cells in naïve C57BL/6J mice. (a) Represented are
dot plots of dual tetramer staining in CD8+ T cells in the unbound (left) or bound (right) fractions after immunomagnetic enrichment using tetramers. (b)
Quantification of TB10.44-11-specific CD8
+ T cells in naïve C57BL/6J mice, either as the total number (left panel) or as the frequency among CD8+ T cells
(right panel). Data are representative from two experiments with 6–10 mice. (c,d,e) Frequency of TB10.44-11-associated TCRβ DNA (c) or amino acid (d,e)
sequences in the T cell repertoire of uninfected C57BL/6J mice. (c) The unique TB10.44-11-associated TCRβDNA sequences from lung#2 were compared
pairwise to the TCRβ repertoire of three uninfected mice (spleen A-C). The frequency of unique TCRβ DNA sequences from uninfected mice are on the y-
axes (blue); fromM. tuberculosis infected lung on the x-axes (red); and sequences detected in both samples are colored purple. The number of unique
sequences in each class is indicated in parentheses. (d) A pairwise comparison of unique TB10.44-11-associated CDR3β amino acid sequences from lung#2
and uninfected spleen B. (e) The frequency distribution of unique CDR3β amino acid sequences in the uninfected TCR repertoire. ‘Uninfected’ consists of all
sequences from uninfected C57BL/6 mice. ‘TB10-specific’ are the TB10-specific sequences found in the uninfected splenic repertoire; ‘shared sequences’
are TB10-specific sequences detected in more than 2 infected mice; ‘expanded sequences’ are all “shared sequences” with frequency >1% in at least one
infected mouse. Box represents minimum and maximum, and bar and dot is the median frequency. NS, not significant; ****, p < 0.0001, by one-way ANOVA
with Kruskal-Wallis post test.
doi:10.1371/journal.ppat.1004849.g003
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had a frequency similar to “uninfected spleen” (0.001559%, not significant). Thus, TB10.44-11-
associated sequences do not appear to be over-represented in the naïve repertoire compared to
other sequences.
Interestingly, the individual frequency of highly represented sequences within an individual
naive mouse varied by more than 10-fold, raising the possibility that the precursor frequency
of individual CDR3β clonotypes could affect their representation in the post-immune reper-
toire (e.g., after infection). Interestingly, “CASSRDRENSDYTF,” which was one of the more
successful CDR3βs as it was commonly detected during Mtb infection, was not present at a
greater frequency than other TCRs in the naïve repertoire (Fig 3E).
Although T cells specific for the immunodominant epitope TB10.44–11 have a high precur-
sor frequency in the naïve repertoire of C57BL/6 mice (Fig 3B), extreme TCR bias emerges dur-
ing the CD8+ T cell response to TB10.44–11 (Fig 2b). While heterogeneity in the frequency of
TB10.44-11-specific clonotypes found in the naïve repertoire could account for some of the bias
(Fig 3E), the precursor frequency of individual clonotypes in the naïve repertoire does not ap-
pear to be the dominant factor influencing representation in the post-infection repertoire. We
next evaluated the possibility that clonotypic dominance occurs because of clonal selection
during infection.
Evidence for antigen-driven peripheral T cell selection
The CDR3 length of the unique TCRβ sequences from the infected and uninfected mice was
similar with a median CDR3β length of 36–39 bases (Fig 4A). In contrast, 56% of the highly
represented TCRs (e.g., frequency>1%) had a CDR3β length of 42. Analysis of the amino acid
sequences with this CDR3β length (accounting for 36% of all TB10.44-11-specific sequences) re-
vealed a strong consensus motif—“CASSxDReNsdytF” (Fig 4B). This motif was present in
clonal expansions if different mice, and several distinct DNA recombination events generate
the conserved aspartic acid (Asp, “D”) at CDR3β residue 6 (e.g., V-D recombination, germline
encoded, N region addition; Fig 4C). Thus, we conclude that this residue is under strong
selection.
In addition to the selection of the conserved Asp, the over-representation of certain CDR3β
regions in their entirety appeared to be the consequence of selection. In Mouse #1, 63% of the
CDR3β sequences encoded the amino acid sequence “CASSLDRENSDYTF.” Remarkably,
three distinct VDJ recombination events generated this CDR3β in Mouse #1 (Fig 4C). These
data strongly suggest that these TCRs were selected. Not only were the TCRβ expansions ex-
tremely biased within each individual mouse, but some abundant sequences shared identical
CDR3βs between mice, constituting so called “public” TCRs [2,23] (Fig 4C).
The “DREN”motif was also detected among TCRs from human lung granulomas in three
of the five patients, and was expanded in patient #24 (Fig 4D). Two different patients share the
motif “CASSxDRENTEAFF,” which is similar to the murine motif (Fig 4D). While the
“DREN”motif was detected in the peripheral blood TCRβ repertoire of normal donors, those
clonotypes had a 10-fold lower average frequency (Fig 4D and S4 Data). Some clonotypes
found in the Mtb granulomas were 1000-fold enriched compared to the average “DREN” fre-
quency in peripheral blood of normal donors (Fig 4D). These data are consistent with selection
since distinct recombination events generate different TCRs with the “DREN”motif (Fig 4D).
Finally, there is evidence for public TCRs as patients #23 and #26 have clones with the identical
CDR3β sequence “CASSSDRENTEAFF”.
The extreme TCR bias (Fig 2C) and the identification of multiple VDJ recombination events
encoding identical CDR3βs indicate that dominant T cell clonotypes undergo selective expan-
sion during infection. To quantify selection during the response toM. tuberculosis, we
CD8+ T Cell Selection during Chronic Infection
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Fig 4. TB10.4-specific CD8+ T cells are selected during infection. (a) Frequency distribution of CDR3β amino acid length of TB10.44-11-specific CD8
+ T
cells from the lungs ofM. tuberculosis infected C57BL/6J mice. (b) Consensus analysis of the CDR3β amino acid sequence of TB10.44-11-specific CD8
+ T
cells with 14 amino acids in length. (c) VDJ DNA rearrangements for the public CDR3βCASSLDRENSDYTF found in four different C57BL/6J mice, showing
Vβ (black), N (red), Dβ (blue), and Jβ (black) sequences. The count and frequency for each sequence in the respective lung is also shown. The box highlights
the nucleotides that encode the conserved aspartic acid (Asp, “D”) and arginine (Arg, “R”) residues. (d) Frequency of human TCRs containing the “DREN”
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calculated the ratio of unique amino acid sequences to unique nucleic acid sequences. For ex-
ample, the same immunodominant CDR3β was encoded by three unique DNA sequences in
mouse #1. Shared sequences (>2 mice) and abundant sequences (>1%) had lower median val-
ues (0.158 and 0.154, respectively) than the bulk population of TB10.44-11-specific CD8
+ T cells
(0.868) or T cells from uninfected mice (0.845), indicating strong selection at the level of the
CDR3β amino acid sequence (p< 0.0001; Fig 4E). Thus, our TCR analysis indicates that clono-
typic dominance occurs because of strong selection of certain CDR3β amino acid sequences.
Retrogenic mouse model for TB10.4-specific CD8+ T cells
To study the biology of TB10.44-11-specific CD8
+ T cells and to delineate the mechanism(s) re-
sponsible for the development of TCR bias duringM. tuberculosis infection, we developed ret-
rogenic mice. To ensure that we could track the recombinant TCR-expressing CD8+ T cells, we
used Vα2var mice, which have a single Vα gene (Vα2) but can still generate diversity through
limited VαJα recombination [24]. Vα2var mice resisted tuberculosis and generated a dominant
TB10.44-11-specific CD8
+ T cell response, although it was more variable than in C57BL/6 mice
(see S5 Data).
Single cell sorting of H2-Kb/TB10.44–11 tetramer
+ cells fromM. tuberculosis-infected
Vα2var mice was followed by single cell PCR to determine the TCRα and TCRβ sequences.
Three mice were analyzed and the TB10.44-11-specific CD8
+ T cell response in each mouse was
dominated by one or two TCR clonotypes (Fig 5A). Each identified dominant TCRβ paired
with a single TCRα chain, supporting that these were true clonal expansions. Despite the con-
strained Vα2, the VαJα recombination site was remarkably diverse. In contrast, there were
structural parallels between the CDR3β sequences from Vα2var (Fig 5B) and C57BL/6 mice
(Figs 2 and 3). While the dominant TCRβs from the Vα2var mice used distinct Vβs and Jβs,
there was enrichment of arginine (“R”) and aspartic acid (“D”) in the CDR3β (Fig 5B and 5C).
To determine whether the enrichment of “R” or “D” was significant, we assessed their occur-
rence in the normal TCRβ repertoire. We queried the splenic TCRβ repertoire from three
C57BL/6 mice representing over 1.1 million reads and ~53,000 unique sequences each (Fig
2A). The average frequency of “R”, “D”, or “RD” at CDR3β position 6, 7, or 6–7, was 10.1%,
7.5%, and 2.5% respectively, indicating “R”, “D”, and “RD” were significantly enriched among
the clonally expanded TB10.44-11-specific CD8
+ T cells (P< 0.0001; see S6 Data).
The four dominant TCRs were cloned into retroviral vectors linked by the 2A sequence al-
lowing the production of four different retrogenic mice (named Rg1 to Rg4, see S10 Data) that
expressed greater numbers of CD8+ T cells specific for TB10.44–11 (Fig 5D). We confirmed that
the correct TCRs were expressed based on expression of the expected Vα and Vβ chains by
CD8+ T cells from the retrogenic mice (Fig 5D). The four TCRs cloned were shown to be spe-
cific for TB10.44–11 based on their binding to tetramers and activation of effector functions fol-
lowing stimulation with the TB10.44–11 peptide (Fig 5E–5G).
motif among normal PBMC or CD8+ T cells from TB patients. Each point represents a unique clonotype and their corresponding CDR3β amino acid
sequences are shown for some. (e) Ratio of unique amino acid clones to nucleotide sequences in T cells from naïve and infected C57BL/6J mice. TCR
sequences were analyzed from uninfected ‘B6 spleen’ (n = 3 mice); infected ‘Mtb lung’ (TB10.44-11-specific CD8
+ T cells; n = 6 mice); or the following subsets
of sequences: ‘frequent’ (>1% of the TB10-specific sequences) or ‘shared sequences’ (TB10.44-11-specific TCRs present in at least 2 mice). ****, p < 0.05
by one-way ANOVA and Holm-Sidak’s multiple comparison test.
doi:10.1371/journal.ppat.1004849.g004
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Fig 5. A retrogenic mousemodel for TB10-specific CD8+ T cells. (a) Frequency and amino acid
sequences of CDR3α (top panel) and CDR3β (bottom panel) regions of TB10.44-11-specific CD8
+ T cells from
the lung of individual Vα2var mice infected withM. tuberculosis. Data were obtained by single-cell sorting and
sequencing of 60–200 cells per mouse (n = 3). (b) Sequences of CDR3α (top panel) and CDR3β (bottom
panel) amino acid sequences of the dominant clones of TB10.44-11-specific CD8
+ T cells expanded in the
lung of Vα2var mice infected withM. tuberculosis. Dashes are gaps introduced for purpose of sequence
alignment. (c) VDJ rearrangement (CDR3β) of the dominant TB10.44-11-specific CD8
+ clonotypes from the
lung of Vα2var mice infected withM. tuberculosis, displaying Vβ (black), N (red), Dβ (blue), and Jβ (black)
sequences. Boxed codon is the conserved arginine (Arg, “R”). (d,e) Flow-cytometry analysis of T cells from
uninfected retrogenic mice expressing TCR3. (d) Represented are a dot plot of CD4 vs CD8 staining of CD3+
T cells (left panel), histograms of GFP expression within CD8+ T cells (middle panel), and a dot plot of Vα2 vs.
Vβ11 staining in CD8+ T cells (right panel). Red, CD4+ T cells; blue, are colored in CD8+GFP- T cells; green,
CD8+GFP+ T cells. The numbers represent: the frequency of CD4+ vs. CD8+ T cells among gated CD3+ T
cells (left); the frequency of CD3+CD8+ cells that express GFP (middle); and the frequency of
CD3+CD8+GFP+ cells that are Vα2+Vβ11+ (right). (e) Tetramer staining of CD8+GFP- T cells (dashed line)
and CD8+GFP+ T cells (filled green histogram). The numbers represent the frequency of CD3+CD8+GFP+
cells that are stained by the tetramer. (f) IFNγ production by lung T cells from TCR3 retrogenic mice infected
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Priming and acquisition of effector function by naïve TB10.44-11-specific
CD8+ T cells
Naïve (CD44loCD62Lhi) Rg3 CD8+ T cells were purified and transferred into congenically
marked recipient mice infected withM. tuberculosis. Immediately after transfer (d6 or d7 after
infection) very few Rg CD8+ T cells were detected (~100–200 cells per lung) and they were
mostly naïve (Fig 6A). Rg CD8+ T cells began to acquire an activated phenotype
(CD44hiCD62Llo) starting on d11 in the LN. Associated with their activation, the numbers of
Rg3 CD8+ T cells in the LN dramatically increased during days 11–13 post-infection (Fig 6A).
Subsequently, these Rg CD8+ T cells began to accumulate in the lung by day 13–15, and the
Rg3 CD8+ T cell numbers continued to increase through day 18 (Fig 6A). The increase in cell
numbers in the LN and lung correlated with proliferation, occurring first in the LN, then in the
lung, and finally in the spleen (Fig 6B). Thus, priming of Rg3 CD8+ T cells tracks the kinetics
that has been established for the IFNγ-response in intact mice and activation of transferred
transgenic CD4+ T cells [25–28]. Following priming, the Rg3 CD8+ T cells rapidly acquired the
ability to produce IFNγ in both the LN and lung (Fig 6C). Thus, Rg3 CD8+ T cells are primed
in the LN and are subsequently recruited to the lung, where they express a variety of effector
functions including the production of IFNγ, TNF, and granzyme B (see S7 Data), similar to en-
dogenous TB10.44-11-specific CD8
+ T cells.
TAP1 and IFNγ are required for protection mediated by CD8+ T cells
It is unknown whether the immunodominant CD8+ T cell response to TB10.4 is protective.
Therefore, we activated Rg3 CD8+ T cells in vitro with TB10.44–11 peptide, IL-2 and IL-12 and
after 60–72 hours, transferred them into sublethally irradiated mice and infected them withM.
tuberculosis. We compared the protective capacity of Rg3 CD8+ T cells with ovalbumin-specific
CD8+ T cells (e.g., OT-I cells).
When a large number of activated cells (e.g., 106) were transferred, both Rg3 and OT-I cells
transferred considerable protection (Fig 7A). The ability of large numbers of OT-I cells to
transfer protection has not been directly investigated, but may be due to their highly activated
state and could involve the production of IFNγ, has shown previously for ovalbumin-specific
CD4+ T cells [29]. As the number of transferred cells was titrated down, protection mediated
by OT-I cells diminished (Fig 7A). In contrast, Rg3 cells continued to mediate significant pro-
tection even when as few as 10,000 cells were transferred (Fig 7A). Transfer of Rg4 T cells also
conferred protection againstM. tuberculosis challenge (see S8A Data).
To demonstrate that protection required TCR dependent recognition of antigen, we trans-
ferred activated Rg3 cells (106 cells/mouse) into sublethally irradiated WT or TAP1-/- recipient
mice. Rg3 effector CD8+ T cells were able to transfer protection to WT but not TAP1-/- recipi-
ents (Fig 7B). As in vitro activation bypasses the need for in vivo priming, these results show
that protection mediated by Rg3 CD8+ T cells requires recognition of antigens processed by
the TAP-dependent class I MHC antigen-processing pathway.
We next determined which effector functions were required for protection. Rg3 mice were
produced in an IFNγ-/- background and IFNγ-/- Rg3 CD8+ T cells compared to WT Rg3 CD8+
withM. tuberculosis. Lung cells were stimulated with TB10.44-11-peptide and analyzed by intracellular
cytokine staining and flow cytometry. Represented are CD8+GFP+ T cells stimulated by TB10.44-11-peptide
(filled green histogram) or left unstimulated (dashed line). The numbers represent the frequency of
CD3+CD8+GFP+ cells that produce IFNγ after peptide stimulation. (g) Specific lysis of TB10.44-11-peptide
pulsed EL4 targets by TCR3 retrogenic T cells at different effector to target ratios. Data are representative of
>10 (d, e), >5 (f), and 3 (g) independent experiments.
doi:10.1371/journal.ppat.1004849.g005
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T cells for their ability to transfer protection. Under our experimental conditions, activated
WT Rg3 CD8+ T cells (106 cells/mouse) transferred significantly more protection than OT-I or
IFNγ-/- Rg CD8+ T cells (Fig 7C). These results show that transfer of protection by TB10.4-spe-
cific Rg CD8+ T cells requires IFNγ production (Fig 7C). Furthermore, naïve Rg3 CD8+ T cells
(105 cells/mouse) prolonged the survival ofM. tuberculosis-infected TCRα-/- mice in an
Fig 6. Retrogenic T cell priming and acquisition of effector functions. (a) Kinetic analysis of frequency (filled circles) and number (opened circles) of
activated (CD44HiCD62LLo) Rg cells in the draining LN (left panel) and lung (right panel) following adoptive transfer into mice infected withM. tuberculosis.
(b) Kinetic analysis of frequency of divided Rg cells in the draining LN, lung and spleen following adoptive transfer into mice infected withM. tuberculosis. (c)
Kinetic analysis of frequency of IFNγ-producing Rg cells in the draining LN (left panel) and lung (right panel) following adoptive transfer into mice infected with
M. tuberculosis. Data are representative from two (b) or three (a, c) independent experiments, each with 5 mice per group. (a,c) One way ANOVA with
Dunnett’s post test to compare differences over time (vs. day 7 [a] or d11 [c]) time points. P<0.05 indicated by asterisks (phenotype or IFNγ) or hash marks
(cell numbers). (b) One way ANOVAwith Tukey’s post test to compare differences in proliferation between lung, LN and spleen; p<0.05 indicated
by asterisks.
doi:10.1371/journal.ppat.1004849.g006
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IFNγ-dependent manner (Fig 7D). Collectively, these data show that TB10.4-specific CD8+ T
cells can controlM. tuberculosis infection and IFNγ production after recognition of antigen
presented in vivo is required for protection.
Differences in TCR avidity can determine clonotypic dominance during
infection
Two of the cloned TCRs (Rg3 and Rg4) differed in their binding to Kb/TB10.44–11 tetramers,
revealing a difference in avidity (Fig 8A). No difference in the level of TCR level was detected
(see S8B Data). Importantly, when transferred separately into intact mice, both Rg3 and Rg4
Fig 7. TAP1 and IFNγ are required for protection mediated by TB10-specific CD8+ T cells. (a,b) Bacterial burden in the lung 21 days after adoptive
transfer of in vitro stimulated Rg (a,b) or OT-I (a) CD8+ T cells into sub-lethally irradiated,M. tuberculosis-infected C57BL/6J (a,b) or TAP-1 deficient (b)
recipients. (c) Bacterial burden in the lung 21 d after adoptive transfer of in vitro stimulated Rg, IFNγ-/- Rg, or OT-I CD8+ T cells into sub-lethally irradiated,M.
tuberculosis-infected C57BL/6J recipients. (d) Survival curves after adoptive transfer of naïve Rg or IFNγ-/- Rg CD8+ T cells intoM. tuberculosis-infected
TCRα-/- recipients. Transfers used 106 cells/mouse in “b” and “c” or 105 cells/mouse in “d”. Statistical significance calculated using the method of the Log-
rank (Mantel-Cox) test. Data are representative from two independent experiments, each with at least 5 mice per group. Other statistical testing done by one-
way ANOVA and ad hoc post tests. NS, not significant; *, p < 0.05.
doi:10.1371/journal.ppat.1004849.g007
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Fig 8. Differences in TCR affinity can lead to clonotypic dominance during infection. (a) Flow-cytometry analysis of affinity of Rg T cells from uninfected
retrogenic mice expressing TCR3 (open circles) or TCR4 (filled circles), based on the frequency of tetramer staining of Rg cells across multiple tetramer
concentrations. (b,c) Kinetic analysis of frequency (b) and number (c) of TCR3 (open symbols) or TCR4 (filled symbols) Rg cells in the draining LN (left
panels) and lung (right panels) following adoptive co-transfer into mice infected withM. tuberculosis. Data are representative from two (b, c) or three (a)
independent experiments, each with 5 mice per group. (b, c) Two way ANOVA with Holm-Sidak’s multiple comparison test; *, p < 0.05).
doi:10.1371/journal.ppat.1004849.g008
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were primed, underwent expansion and trafficked to the lung with similar kinetics, and medi-
ated protection (Figs 6 and 7 and see S8 Data). To investigate whether TCR avidity could affect
immunodominance, we co-transferred naïve Rg cells expressing either TCR3 or TCR4 at a 1:1
ratio into congenic recipients and analyzed their relative abundance following infection. Fol-
lowing co-transfer intoM. tuberculosis infected mice, Rg3 and Rg4 T cells initially maintained
a 1:1 ratio and importantly, both Rg3 and Rg4 T cells were primed in the LN and increased in
number (Fig 8B and 8C). However, by day 11 post infection, Rg4 T cells began to outnumber
Rg3 T cells, and by day 14, Rg4 T cells outnumbered Rg3 T cells by a ratio of 10:1 in the LN
(Fig 8B and 8C). In the lung, there was no change in the ratio or cell count until day 14, at
which point Rg4 CD8+ T cells accounted for>90% of the Rg CD8+ T cells (Fig 8B). While the
absolute number of both Rg3 and Rg4 CD8+ T cells increased in the lung by day 20, Rg4 CD8+
T cells outnumber Rg3 CD8+ T cells by 100:1 (Fig 8C). Although both Rg3 and Rg4 were able
to expand and confer protection when transferred separately, Rg4 T cells dominated when in
competition with Rg3 T cells. When co-transferred, both Rg3 and Rg4 CD8+ T cells were
primed in the LN and proliferated; however, small differences in their affinity led to the estab-
lishment of clonotypic dominance by Rg4 CD8+ T cells during the T cell response toM.
tuberculosis infection.
Discussion
We report that extreme TCR bias develops during the polyclonal CD8+ T cell response to a sin-
gle immunodominant epitope during tuberculosis in humans and in mice. In mice, preferential
Vβ use by TB10.44-11-specific CD8
+ T cells is detected in the LN within 3 weeks of infection, in-
dicating that bias develops soon after T cell priming. With time, TCR clonality becomes more
extreme. Why do a few clonotypes dominate the TB10.44-11-specific CD8
+ T cells duringM. tu-
berculosis infection?
TCR diversity arises by three principal mechanisms: 1) V, D, and J segments generate com-
binatorial diversity; 2) imprecise recombination and insertion of non-templated ‘N’ sequences
at the VβD, DJβ and VαJα junctions; and 3) random assortment between TCRα and TCRβ
chains [30,31]. By these mechanisms, people have the potential to generate>1014 unique
TCRαβ receptors [1,32]. Thymic selection constrains the repertoire by ensuring that T cells
that are unable to recognize MHC and the T cells that recognize self-antigens with high affinity
are deleted. As a result, people have ~1010 T cells and each clonotype is represented by 10–500
T cells; therefore, the number of unique TCRs in any individual (~2.5 x 107) is far fewer than
the number of potential TCRs [2,3]. Although sharing of TCRs between people is improbable,
such ‘public’ TCRs are detected and may have special significance [23].
If the number of antigen-specific T cells in the naïve repertoire is limiting, clonotypic domi-
nance could arise by a “founder” effect in which few T cells are primed and expand, leading to
T cell populations of restricted diversity. A founder effect is unlikely to explain the TCR bias
among TB10.44-11-specific CD8
+ T cells because we detect ~900 naïve T cells in each C57BL/6
mouse, a precursor frequency that is among the highest recorded for antigen-specific CD8+ T
cells in the mouse [7]. TB10.44-11-tetramer
+ CD8+ T cells from the LNs of infected mice use
many Vβ families, which also argues against a founder effect. Another possibility is that the fre-
quency of each clonotype in the naïve repertoire is skewed and results in TCR bias after infec-
tion. We observe considerable heterogeneity in the relative abundance of naïve precursors with
the potential to recognize the TB10.44–11. However, skewing in the naïve repertoire cannot
solely explain the selection that we observe for TB10.44-11-specific CD8
+ T cells following
infection.
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After infection, TB10.44-11-specific CD8
+ T cells express a limited number of CDR3β se-
quences. Given the high precursor frequency, we predicted a priori that the response would be
dominated by private clonotypes, i.e., TCRs unique to each individual. Instead, common
CDR3βmotifs are generated by independent VDJ recombination events, within the same
mouse and among different individuals. The most frequently used and shared TCRβs are
under selective pressure, determined using a modification of Warren’s method [33].
Developing retrogenic mice that over-produce CD8+ T cells specific for TB10.44–11 permit-
ted us to perform competition experiments with naïve TB10.44-11-specific CD8
+ T cells. A
small difference in affinity significantly affects clonal representation and establishment of hier-
archical dominance during infection. These data provide crucial experimental support for the
idea of antigen-driven selection based on our TCR analysis. Although TCR affinity seems to be
a major factor driving immunodominance, other factors can contribute. For example, the in-
flammatory environment and tissue-specific cues influence the fate of individual CD8+ T cells
during infection [4], and these factors may contribute to the establishment of immunodomi-
nant T cell responses during tuberculosis.
Why is TB10.4 an immunodominant antigen? While there is a high precursor frequency,
few of these T cell clones are significantly represented in the final immune response. The lack
of a correlation between the precursor frequency and immunodominance in C57BL/6 and
BALB/c mice [ref:10] indicates that a high precursor frequency is not a prerequisite for immu-
nodominance during chronic infection. TB10.4 belongs to a larger family of ESAT6-related
proteins that are secreted by specialized type VII secretion systems, and many of the secreted
proteins are immunodominant in different animal species and humans [34–36]. While the
abundance of TB10.4 during infection is unknown, paucity of this antigen during T cell prim-
ing or limited antigen presentation in the infected lung could drive clonotypic dominance by
selecting for higher affinity T cells.
Whether certain mycobacterial antigens that elicit immunodominant T cell responses act as
“decoys” to distract the immune response from responding to subdominant epitopes that
might be more important targets of protective immunity was raised by Baena and Porcelli [37].
The finding that portions of the mycobacterial genome that encode T cell epitopes was more
evolutionarily conserved has fueled this idea and raised the possibility that T cell immunity
could benefitM. tuberculosis, possibly by creating an inflammatory environment that facilitates
transmission [38]. Work done by the Andersen group finds that cryptic epitopes of ESAT6 are
minor components of natural immune response to M. tuberculosis but specific vaccination
strategies that elicit CD4+ T cells specific for the subdominant epitopes generate more durable
protection against tuberculosis [39–41].
Could TCR diversity (or bias) be a surrogate for the quality or effectiveness of T cell immu-
nity? Spectratyping of peripheral blood T cells from tuberculosis patients reveals TCR skewing
compared to healthy controls [20,42,43]. Extreme TCR bias (e.g., clonality) was noted primari-
ly in the setting of severe clinical disease, raising the possibility that TCR bias is associated with
disease progression [19,20]. Arguing against this interpretation is the presence of highly
skewed TCR repertoires in lung granulomas from patients with latent tuberculosis [17]. In our
cohort of patients, we also see the emergence of clonal T cell expansions in the lungs of patients
with active disease, compared to the frequency of T cells in the peripheral blood of normal do-
nors. Importantly, clonal expansions can be detected among peripheral blood CD4+ and CD8+
T cell in uninfected healthy individuals, with memory T cells being 50-fold less diverse than
naive T cells [33]. While these data indicate that T cell expansions can occur independently of
active infection, clonotypes expressing the CDR3βmotif “DREN” were 1000-fold enriched in
Mtb granulomas compared to their average frequency in the peripheral blood of normal do-
nors. Thus, these expansions are several orders of magnitude greater than the expansions
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reported in uninfected individuals [33]. This may indicate that the "DREN" expansions are
driven by Mtb infection. Furthermore, based on our murine data, we infer that T cell selection,
possibly driven by affinity, is occurring. We are confident that we captured the majority of lung
TB10.4-specific CD8+ T cells present in each individual mouse. In contrast, we observed con-
siderable heterogeneity in the TCR repertoire obtained from distinct granulomas in each
human subject. While this heterogeneity is not surprising based on the work on Flynn and
Barry [44,45], it is important to recognize that TCR bias at the level of the granuloma may be
driven by heterogeneity in bacteria and bacterial antigens, as well as the persistent immune re-
sponse. Therefore, the links between TCR bias, functional capacity of T cells and protection
during tuberculosis are still unclear, and longitudinal studies coupled with the functional study
of antigen-specific T cells are needed to define what constitutes a protective T cell response
against tuberculosis in both people and in experimental animal models, both in terms of TCR
diversity and T cell function [46].
While antigen choice is a key part of vaccine development, predicting which immunogenic
epitopes elicit memory responses that generate protective immunity during infection has not
been straightforward. Some pathogens mutate to escape T cell surveillance; other pathogens
avoid immune detection by sequestering their antigens. CD4+ and CD8+ T cells specific for
TB10.4 are elicited following clinical tuberculosis infection. Based on the ability of TB10.4-spe-
cific CD4+ T cells to mediate protection in animal models, the TB10.4 antigen has been incor-
porated into subunit vaccines. Our data is the first to show that TB10.4-specific CD8+ T cells
transfer protection and that protection requires antigen presentation by TAP1-dependent
pathways. This implies that the TCR-mediated recognition of infected cells is a prerequisite for
the antimicrobial activity of CD8+ T cells. Furthermore, IFNγ is a key mediator of bacterial
control.
Why then did a vaccine designed to elicit TB10.4-specific CD8+ T cells fail to protect mice
againstM. tuberculosis [47]? We chose to measure protection in immunocompromised (e.g.,
sublethally irradiated) mice, as it is difficult to demonstrate CD8+ T cell mediated protection
in mice with an intact CD4+ T cell compartment. Another factor that may impair the ability of
TB10.4-specific CD8+ T cells to protect mice with an intact immune system is inefficient pre-
sentation of IMYNYPAM. Lindenstrom et al show that vaccination with native TB10.4 protein
does not elicit TB10.4-specific CD8+ T cells because the amino acid sequence surrounding the
epitope (e.g., IMYNYPAML) is inefficiently processed and presented. In contrast, a homolo-
gous protein (TB10.3, EsxR) contains a homologous sequence (e.g., IMYNYPAMM), which is
more efficiently processed and presented. Less TB10.3 is produced by the bacterium than
TB10.4, and because of this, Lindenstrom speculates that IMYNYPAM is not presented effi-
ciently by infected macrophages. Our own data showing protection (Fig 7) used cells activated
in vitro prior to adoptive transfer, bypassing the need for priming. TAP1-dependent protection
mediated by these TB10.4-specific CD8+ T cells implies that infected cells in the lung present
IMYNYPAM. However, the source of the antigen (e.g., TB10.3 vs. TB10.4) is uncertain. If
IMYNYPAM-specific CD8+ T cells recognize the small amount of TB10.3 expressed by in-
fected macrophages, then selecting CD8+ T cells with a high affinity for IMYNYPAM will be
even more important for host resistance.
Our study took advantage of the well-characterized CD8+ T cell response to Mtb in mice,
where responses to an epitope of TB10.4 elicit an immunodominant T cell response. This al-
lowed us to track and purify antigen-specific CD8+ T cells during infection. We find that the
TB10.4-specific CD8+ T cell response is characterized by extreme clonality despite originating
from a high-frequency naïve precursor pool. We were able to show that structural features of
the CDR3β region were important for epitope recognition, most likely because of clonal com-
petition and affinity selection. Similarly, we found that human CD8+ T cells also undergo
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selection and clonal expansion. Although the clonal expansions we detected in humans were
not as dramatic as in the mouse model, we believe that this is partially because we were unable
to purify human antigen-specific CD8+ T cells, due to the lack of appropriate reagents. The
ability to use tetramer-sorted cells allows one to analyze T cells that are all specific for a single
epitope, which adds considerable power to the TCR analysis. Therefore, it is uncertain whether
the extreme immunodominance we observe in the murine system will be found in humans,
and this is the subject of active investigation. For example, greater T cell diversity is theoretical-
ly expected in humans, due to the contributions of HLA variability, but also empirically, as
demonstrated by the large-scale studies to date that have generally found a more diverse T cell
response in infected individuals [48,49]. However, this may also be due to technical barriers;
while antigen-specific CD8+ T cell expansions are found during tuberculosis, they often appear
to be unique to individuals and their private repertoires, which further complicates TCR analy-
sis of antigen-specific T cells [48–50]. If this holds true, it could be difficult to fully exploit TCR
analysis as a biomarker for following disease progression or treatment efficacy, although if ex-
panded T cell clones from the lung are correlated with those that are present (and can be de-
tected) in peripheral blood, algorithms might be developed that are independent of antigen-
specificity.
Finally, based on the propensity of Mtb to drive clonal selection of CD8+ T cells, we infer
that there is a paucity of antigen presentation in the infected lung. Such a state may arise be-
cause of inefficient cross-presentation of antigens by the class I MHC-processing pathway and
could explain why CD8+ T cells have not proven to be as protective as CD4+ T cells. Similarly,
if low levels of antigen presentation rapidly select for high affinity CD8+ T cells during infec-
tion, an effective vaccine will need to elicit similarly high affinity T cells, rather than large num-
bers of diverse T cells, if they are to be effective in controlling bacterial replication.
Materials and Methods
Ethics statement
The University of KwaZulu Natal (UKZN) Biomedical Research Ethics Committee (BREC) ap-
proved the study protocol, its associated informed consent documents and data collection
tools. Written informed consent was obtained for all research subjects.
All animal experiments were performed in accordance with National and European Com-
mission guidelines for the care and handling of laboratory animals. The studies were approved
by the Institutional Animal Care and Use Committee at the Dana Farber Cancer Institute and
the University of Massachusetts Medical School (Animal Welfare Assurance no. A3023-01
[DFCI] or A3306-01 [UMMS]), under Public Health Service assurance of Office of Laboratory
Animal Welfare guidelines).
Human granuloma T cells
Lung tissue of approximately 3 cm3 was isolated from different areas of resected lungs, corre-
sponding to the most diseased (A), intermediate (B), and healthiest tissue (C), typically corre-
sponding the upper (A), lower (B) and middle lobe (C) (Table 1). The operating surgeon
classified the tissue based on their experience and the pre-operative radiological data. Each
sample was washed in multiple changes of HBSS and then diced into approximately 1 mm3
pieces, which were strained, re-suspended in 7mls of pre-warmed digestion media (R10 (RPMI
supplemented with 10% FCS, 2 mM L-glutamate, 100 U/ml Penstrep), containing 0.5 mg/ml
collagenase D (Roche) and 40 U/ml DNaseI (Roche), and transferred to GentleMACS C-tubes
(Miltenyi) for mechanical digestion per manufacturers instructions. The resultant suspension
was incubated for 60 min at 37 oC, subjected an additional mechanical digestion step. The
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resulting suspension was strained through a 70 μm cell strainer, washed twice in HBSS, stained
and CD8+ T-cells sorted using the FACS ARIA system, gating on the live (nearIR, Invitrogen)
singlet, CD45+, CD3+ and CD4- population. Cells were sorted directly into RLT buffer, and ge-
nomic DNA extracted using the DNeasy Minikit (Qiagen) as per manufactures instructions.
Mice
C57BL/6 (WT), CD45.1 (B6.SJL-PtprcaPepcb/BoyJ), CD90.1 (B6.PL-Thy1a/CyJ), OT-I
(C57BL/6-Tg(TcrαTcrβ)1100Mjb/J), TCRα KO (B6.129S2-Tcratm1Mom/J), IFNγ KO
(B6.129S7-Ifngtm1Ts/J) and TAP KO (B6.129S2-Tap1tm1Arp/J) mice were purchased from Jack-
son Laboratories (Bar Harbor, ME). Va2var mice [24] were bred at Jackson Laboratories (Bar
Harbor, ME). Mice were 6 to 10 weeks old at the start of all experiments. Mice infected withM.
tuberculosis were housed in a biosafety level 3 facility under specific pathogen-free conditions
at DFCI or at UMMS.
Experimental infection and bacterial quantification
M. tuberculosis (Erdman strain) infection was performed via the aerosol route, and mice re-
ceived 50–200 CFU/mouse. A bacterial aliquot was thawed, sonicated twice for 10 s in a cup
horn sonicator, and then diluted in 0.9% NaCl–0.02% Tween 80. A 15 ml suspension ofM. tu-
berculosis was loaded into a nebulizer (MiniHEART nebulizer; Vortran Medical Technologies)
and mice were infected using a nose-only exposure unit (Intox Products). Alternatively, the
bacterial aliquot was diluted in a final volume of 5ml, and mice were infected using a Glas-Col
aerosol-generation device. At different times post-infection, mice were euthanized by carbon
dioxide inhalation, organs were aseptically removed, individually homogenized and viable bac-
teria were enumerated by plating 10-fold serial dilutions of organ homogenates onto 7H11
agar plates. Plates were incubated at 37°C andM. tuberculosis colonies were counted after 21 d.
FACS analysis and cell sorting
Cell suspensions from lung, spleen and LNs were prepared by gentle disruption of the organs
through a 70 μm nylon strainer (Fisher) or using the GentleMacs apparatus (Miltenyi Biotec,
Germany) according to the manufacturer instructions. For lung preparations, tissue was di-
gested for 30–60 min at 37 °C in 1 mg/mL collagenase (Sigma) prior to straining. Erythrocytes
were lysed using a hemolytic solution (155 mMNH4Cl, 10 mM KHCO3, 0.1 mM sodium
EDTA pH 7.2) and, after washing, cells were resuspended in supplemented RPMI (10% heat
inactivated FCS, 10 mMHEPES, 1 mM sodium pyruvate, 2 mM L-glutamine, 50 mg/ml strep-
tomycin and 50 U/ml penicillin, all from Invitrogen) or MACS buffer (Miltenyi Biotec, Ger-
many). Cells were enumerated in 4% trypan blue on a hemocytometer or using a MACSQuant
flow cytometer (Miltenyi Biotec, Germany). Surface staining was performed with antibodies
specific for mouse CD3 (clone 17A2), CD3ε (clone 145-2C11) CD4 (clone GK1.5), CD8 (clone
53–6.7), CD19 (clone 6D5), CD44 (clone IM7), CD62L (clone MEL-14), CD45.1 (clone A20),
CD45.2 (clone 104), CD90.1 (clone OX-7), CD90.2 (clone 53–2.1), Vα2 (clone B20.1), Vβ4
(clone KT4), Vβ5 (clone MR9-4), Vβ7 (clone TR310), Vβ10 (clone B21.5), Vβ11 (clone RR3-
15) (from Biolegend or BD Pharmingen, CA, USA). The specificity of the anti-Vα and-Vβ
mAbs are shown in Table 2. The tetramers TB10.44–11-loaded H-2 K
b were obtained from the
National Institutes of Health Tetramer Core Facility (Emory University Vaccine Center, At-
lanta, GA, USA). All stainings were performed for 20 min on ice and, unless stated, cells were
fixed before acquisition with 2% formaldehyde in PBS for 30–60 min. Cell analysis was per-
formed on a FACS Canto (Becton Dickinson, NJ, USA) or on a MACSQuant flow cytometer
(Miltenyi Biotec, Germany). Data were analyzed using FlowJo Software (Tree Star, OR, USA).
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For cell sorting, stained and non-PFA fixed cells were suspended in MACS buffer (Miltenyi
Biotec, Germany) and deposited in collection tubes using a BD Canto flow cytometer (Becton
Dickinson, NJ, USA). For both FACS analysis and cell sorting, single-lymphocyte events were
gated by forward scatter versus height and side scatter for size and granularity.
Next generation sequencing
For TCRβ high-throughput sequencing, genomic DNA was purified from sorted cell popula-
tions and sequenced by Adaptive Biotechnologies Corp. (Seattle, WA) using the ImmunoSEQ
assay (http://www.immunoseq.com) as previously described[51]. Data were analyzed using the
ImmunoSEQ analyser toolset. Clonality is the entropy of the TCRB frequency distribution and
is calculated as 1-(entropy/log2[# unique TCRs]). Here entropy, a measure of diversity within a
complex data set, is also known as the Shannon-Wiener index, Shannon’s diversity index or
Shannon’s entropy [52,53]. Thus “0” represents a diverse repertoire and “1” is a completely
clonal repertoire.
Enumeration of naïve Ag-specific T cells
Analysis of the precursor frequency of naïve T cells was performed as previously described
[54]. Briefly, the spleen and axillary, mesenteric, cervical, inguinal, popliteal, and salivary LN
were harvested from individual mice, dispersed, and filtered through a 70-mmmesh and enu-
merated for total and CD8+ T cell composition. The cell suspension was then costained with
identical PE- and APC-conjugated tetramers and then purified via anti- PE magnetic bead se-
lection (Miltenyi Biotec, Germany). Positive and negative fractions were then surface stained
with anti-MHC II, CD11b, CD19, and CD4 as a “dump” channel, and anti-CD8α, CD3 and
CD44. Flow cytometry counting beads were added immediately before samples were collected
by the cytometer to determine the fraction of tetramer+ events collected and used to determine
the total number and frequency of tetramer+ cells in each animal. For analysis purposes, naïve
cells were cells that were present in the bound fraction, costained with PE- and APC-conjugat-
ed tetramers, and did not express CD44.
Single cell sorting and single cell PCR
Live lymphocytes were sorted as TCRβ+CD8+Tet+CD19-CD4-CD11b-CD11c- as individual
cells into wells of 96-well PCR plates containing 10 μl of reverse transcriptase buffer (50 mM
Tris-HCl, 75 mM KCl, and 3 mMMgCl2), 2% Triton X-100, 500 μM dNTP with 1 μg BSA, 50
ng of oligo(dT) (12–18), 500 μMdTT, 50 μM of TCRα-specific primer, 50 μM of TCRβ-specific
primer, 8 U of RNaseOUT, and 30 U of Moloney murine leukemia virus reverse transcriptase
(Invitrogen Life Technologies). The plates were incubated for 90 min at 37°C, then heat inacti-
vated for 20 min at 80°C. 2 μl of the cDNA were used for each of the nested PCRs for TCRα or
TCRβ (see S9 Data for list of primers). The first round of each nested PCR amplification was
performed by combining 2 μl of cDNA with 9 μl of Taq buffer (50 mM KCl, 10 mM Tris-HCl
(pH 8.3), and 2.5 mMMgCl2), 500 μM dNTP, 0.3 U of Taq polymerase, 50 μM of TRACext- or
TRBCext-specific primer for the constant region and an oligonucleotide mixture of 23 TRAVext
or 19 TRBVext primers (each 50 μM final concentration). For the second round of the nested
reaction, 2 μL of the first reaction were combined with 18 μL of Taq buffer (50 mM KCl,
10 mM Tris-HCl (pH 8.3), and 2.5 mMMgCl2), 500 μM dNTP, 0.6 U of Taq polymerase,
50 μM of TRACint- or TRBCint-specific primer for the constant region and an oligonucleotide
mixture of 23 TRAVint or 19 TRBVint primers (each 50 μM final concentration). The PCR con-
ditions for the first round of PCR were 94°C for 3 min followed by 35 cycles of 94°C for 20 s,
52°C for 45 s, and 72°C for 60 s, with a final extension at 72°C for 7 min. For the second round
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of PCR conditions were the same, but only for 26 PCR cycles. Contamination was monitored
for all steps (sorting, reverse transcriptase, and PCR), by leaving 16 control wells empty per
96-well PCR plate sorted.
For TCR product sequencing, a total of 12 μl of the products from the second round of the
nested PCR amplification was combined with 1.5 μl of 10X shrimp alkaline phosphatase reac-
tion buffer (200 mM Tris-HCl (pH 8.0) and 100 mMMgCl2), 1 U of shrimp alkaline phospha-
tase (Amersham Biosciences), and 1 U of exonuclease I (New England Biolabs), and water to
total 15 μl. The reaction was then heated to 37°C 30 min, 80°C 10 min, and cooled to 4°C, and
the product was subjected to automated sequencing (Dana-Farber/Harvard Cancer Center
High-Throughput Sequencing Core). The sequences of the four TCRs cloned are shown in S10
Data.
Generation of retrogenic mice
TCR retroviral constructs were generated as 2A-linked single open reading frames using PCR
and cloned into a murine stem cell virus-based retroviral vector with a GFP marker as previ-
ously described [55,56]. Details of cloning strategies and primer sequences are available upon
request (samuel.behar@umassmed.edu). Retroviral-mediated stem cell gene transfer was per-
formed as previously described [55,56].
Intracellular cytokine staining
5×105 cells were plated in each well of a round bottom 96-well plate and incubated in the pres-
ence of TB10.44–11 peptide (10 μM; New England Peptide). Incubation in the presence of
αCD3/αCD28 (1 μg/mL; BioLegend) or in the absence of stimuli were used as positive and neg-
ative controls, respectively. Cells were incubated for 1 h at 37° C, at which point Golgi Stop so-
lution (BD Pharmingen, CA, USA) was added to each well for the remaining 4 h. Cells were
collected after the 5 h stimulation and then surface stained with the antibodies described
above, followed by intracellular staining for IFNγ (clone) using BD Permwash Kit (BD Phar-
mingen, CA, USA) as per manufacturer’s instructions.
In vitro CTL assay
In vitro cytotoxicity was determined using peptide- coated EL4 target cells differentially labeled
with the cell proliferation dye efluor 450 (eBiosciences) as previously described [21]. Briefly,
target cells were pulsed with 10 μM of TB10.4 peptide at 37°C for 1 h in complete medium or
left unpulsed (as controls), followed by extensive washing. Target cell populations were then la-
beled with either 10 μM or 100 nM e450 dye in PBS for 20 min at room temperature, followed
by extensive washing. Labeled populations were mixed at an equal cell ratio with effector retro-
genic cells at 1:1:1 ratio in round bottom 96-well plates (100,000 cells/population, in triplicate).
Plates were incubated for 4–12 h at 37°C, in the dark. After incubation, the cells were analyzed
by flow cytometry, and the ratios of recovered GFP (retrogenic, effector) and e450-labeled tar-
get EL4 populations were determined.
Adoptive T cell transfer for priming and competition
Single cell suspensions of pools of spleens and LNs from naive retrogenic mice (6 to 10 wks
post reconstitution) were prepared. CD8+ T cells were purified from each suspension using the
CD8+ T cell isolation kit and magnetic separation (Miltenyi Biotec, Germany). After purifica-
tion, cells were counted and transferred via the tail vein into congenically marked recipients
(CD90.1), which had been infected 6–7 d earlier with virulentM. tuberculosis (Erdman) via the
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aerosol route. For priming experiments, 104 to 105 cells were transferred into each recipient.
For competition experiments, cells were mixed at a 1:1 ratio (confirmed by FACS analysis prior
to injection) and then transferred into each recipient.
Measurement of cell proliferation
For analysis of cell proliferation of retrogenic cells after adoptive transfer, bead-purified naïve
Rg cells (see above) were labeled with 10 μM of the cell proliferation dye efluor 450 (eBios-
ciences) in PBS for 20 min at room temperature, followed by extensive washing.
In vitro activation of T cells
Single cell suspensions of pools of spleens and LNs from naive retrogenic or OT-I mice were
prepared. CD8+ T cells were purified from each suspension using the CD8+ T cell isolation kit
and magnetic separation (Miltenyi Biotec, Germany). After purification, cells were counted
and mixed at a 1:1 ratio with peptide coated APCs in media containing 100U/mL of IL-2 and
10U/mL of IL-12. APCs used were red blood cell lysed splenocytes from naïve C57Bl6/j mice,
pulsed with 10 μM of TB10.4 or SIINFEKL peptide at 37°C for 1 h in complete medium, fol-
lowed by irradiation with 3200 Rads from a cesium-137 source and extensive washing. 2x106
cells were plated, 1 mL into each well of a 24 well plate. After 24 h, cells were fed with 1 mL of
fresh media, containing 100U/mL of IL-2 and 10U/mL of IL-12. 48 h after the initial stimula-
tion, cells were fed by removing 1 mL of culture media and addition of 1 mL of fresh media,
containing 100U/mL of IL-2. 60–72 h after the initial stimulation, cells were extensively washed
with complete media, and used for adoptive transfer experiments.
Adoptive T cell transfer for protection and survival
An adoptive transfer model was used to analyze the ability of T cells to mediate protection
against pulmonaryM. tuberculosis infection as previously described [21]. Briefly, C57BL/6 or
TAP-ko mice were sublethally irradiated with 600 rad using a cesium-137 source. The next
day, 104 to 106 bead-purified activated Rg T cells (or OT-1 cells, as controls) were transferred
via the tail vein. Mice were infected with virulentM. tuberculosis (Erdman) via the aerosol
route within 24 h of the adoptive T cell transfer. Three weeks after infection, the bacterial bur-
den in the lung and spleen was determined. For survival experiments, naïve T cells (105 per
mouse) were transferred into TCRα KOmice via the tail vein; following transfer, mice were in-
fected with virulentM. tuberculosis (Erdman) via the aerosol route.
Statistical analysis
Population medians were used to compare TCR frequencies. Other data are represented as
mean + SEM. For data with a verified for Gaussian distribution, a t-test was performed to com-
pare two groups; otherwise, a Mann-Whitney U test was used. To compare more than 2 groups,
one-way ANOVA, followed by Bonferroni post-hoc test was performed. Differences with a
p<0.05 were considered significant and represented by .
Supporting Information
S1 Data. Deep Sequencing of human TCRs from TB granulomas. Summary of deep se-
quencing data of human TCRβs from lung granulomas and lymph node resected from subjects
with tuberculosis.
(PDF)
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S2 Data. Clonality and clonality distribution. A. The Vβ gene distribution is shown for two
samples: (top) CD8+ T cells from a human lung granulomas; and (B) PBMC from a normal
donor. One can see how differences in the Vβ gene use affects the calculation of clonality can
be visualized. Numbers do not add to 100% because only productive recombination events are
plotted. Width axis: V gene; Depth Axis: CDR3 length; Height axis: frequency. B. The Vβ gene
distribution is shown for four samples from a single subject (#23): lung sample A, B, and C;
and LN. Although there are considerable differences between the samples, particularly with re-
spect to TCR diversity (see Fig 1), the most abundant TCRs are shared between the different
lung lesions and to a lesser extent, the LN sample. Again, one can visualize how the Vβ gene
use affects clonality. Width axis: V gene; Depth Axis: CDR3 length; Height axis: frequency.
(PDF)
S3 Data. TCRβ frequencies in human lung granulomas. The TCRβ frequencies, derived for
the frequency of unique DNA sequences, in each sample analyzed by deep sequencing. The bar
is the median and the error bars denote the interquartile range. For comparison, the TCRβ fre-
quencies in PBMC from three normal donors are shown. Only productive recombination
events are plotted.
(PDF)
S4 Data. DREN motif in human TCRs. The frequency of the “DREN”motif in the CDR3 re-
gion of TCRβ chains sequenced from human granulomas or PBMC samples from normal indi-
viduals. Multiple unique sequences were detected in these samples. The frequency of “DREN”
motifs was elevated in lung granuloma compared to peripheral blood. Statistical testing after
log10 transformation showed that these differences were significant (P<0.001) for all pairwise
combinations by one-way ANOVA with Tukey’s multiple comparison test. These data show
that TCRβ chains with the “DREN” CDR3 motif are increased in frequency among CD8+ T
cells in tuberculous lung granulomas compared to peripheral blood T cells from
healthy controls.
(PDF)
S5 Data. Infection of Vα2var mice with Mtb. A. Schematic of the Vα2var locus of Vα2var
mice. B. The TB10.44-11-specific CD8
+ T cell response following aerosol infection of WT vs.
Vα2var mice. C. Survival of C57BL/6, Vα2var, or TCRα knockout mice after low dose aerosol-
ized Mtb.
(PDF)
S6 Data. Frequency of arginine and aspartic acid in naïve cells. To determine whether the
enrichment of “R” or “D” was significant, we compared their occurrence in the normal TCRβ
repertoire. We queried the splenic TCRβ repertoire from three C57BL/6 mice representing
over 1.1 million reads and ~53,000 unique sequences each. The average frequency of “R”, “D”,
or “RD” at CDR3β position 6, 7, or 6–7, was 10.1%, 7.5%, and 2.5% respectively, indicating
“R,” “D,” and “RD,” were significantly enriched in the clonally expanded TB10.44-11-specific
CD8+ T cells. Testing using the Chi-square with Yates' correction shows that the frequency of
R, D, or RD in the clonally expanded sequences is significantly increased in the four cloned se-
quences compared to the normal splenic repertoire of B6 mice (P<0.0001).
(PDF)
S7 Data. Effector function of Rg3 CD8+ T cells. Rg3 CD8+ T cells were transferred to Mtb in-
fected mice as described in the methods. Three to six weeks after aerosolized Mtb infection,
lung cells were stimulated with the TB10.4 epitope. Intracellular staining for IFNg, IL-2, TNF,
and granzyme were performed. The results shown are gate on Rg3 CD8+ T cells identified by
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their co-expression of GFP and Va2
(PDF)
S8 Data. Rg4 CD8+ T cells mediate protection and are primed in the lungs of Mtb infected
mice. A. Protection mediated by 106, 105 or 104 in vitro activated Rg4 (e.g., TCR4) CD8+ T
cells. T cells were transferred by the IV route into sublethally irradiated mice and challenged
with Mtb. CFU were determined ~ 4 wks after infection. Protection (Δlog10) is the lung CFU
in mice that did not receive Rg T cells minus the lung CFU in mice that did receive Rg T cells.
Two independent experiments are shown each with 5 mice. One way ANOVA with Tukey’s
post test to compare differences in CFU. , p<0.05; , p<0.001. B. The level of TCRα staining
on Rg3 vs. Rg4 CD8+ T cells from the lungs of infected mice. T test showed the difference was
not significant. C. Priming of naïve Rg4 and Rg3 CD8+ T cells in the pulmonary LN of Mtb in-
fected mice occurs with similar kinetics. Rg3 and Rg4 CD8+ T cells were co-transferred or Rg3
CD8+ T cells were transferred alone. Priming is indicated by acquisition of an activated
(CD44+CD62Llo phenotype.
(PDF)
S9 Data. Primers used for single cell PCR analysis of TCRs used by murine CD8+ T cells.
List of the TCRα and TCRβ primers used for nested PCR for the single cell analysis of TCRs
used by TB10-specific CD8+ T cells from the lungs of Mtb-infected mice.
(PDF)
S10 Data. Retrogenic TCR sequences. TCR sequences and 2A peptide cloned into retroviral
vectors. Sequences of four TCR sequences as assembled and cloned into the retroviral vectors.
The first sequence is color-coded. VαJα (blue); Cα (purple); P2A (grey); VβDJβ (yellow); Cβ
(green).
(PDF)
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